nonfatal
US
・UK
A1 初級
adj.形容詞非致命
影片字幕
降膽固醇新希望？Bempedoic Acid 心血管成效大揭密｜NEJM (Bempedoic Acid and Cardiovascular Outcomes | NEJM)
- After a median follow-up of 40.6 months, the incidence of a primary endpoint event, a composite of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or coronary revascularization, was significantly lower in the bempedoic acid group, at 11.7%, than in the placebo group, at 13.3%.
在中位隨訪 40.6 個月後，主要終點事件（心血管原因導致的死亡、非致命性心肌梗死、非致命性中風或冠狀動脈血運重建的綜合結果）的發生率在魚貝多酸組（11.7%）顯著低於安慰劑組（13.3%）。
- A key secondary efficacy endpoint event, a composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, occurred significantly less often in the bempedoic acid group.
一個關鍵的次要療效終點事件，即心血管原因導致的死亡、非致命性心肌梗死或非致命性中風的複合事件，在貝母雙酸組發生的頻率明顯降低。